Healthcare -
Biotechnology - NASDAQ - US
$ 8.67
9.61 %
$ 738 M
Market Cap
-15.76
P/E
AVXL - OTHER FINANCING ACTIVITIES
Other Financing Activities AVXL - Anavex Life Sciences Corp.
691 K
LAST VALUE
51.01%
2 YEAR CAGR
73.72%
5 YEAR CAGR
11.14%
10 YEAR CAGR